---
schema_version: "secwatch.filing_event.v1"
accession: "0000764478-25-000050"
form_type: "8-K"
ticker: "BBY"
cik: "0000764478"
company_name: "BEST BUY CO INC"
filed_at: "2025-11-25T23:59:59+00:00"
generated_at: "2026-05-16T17:08:46.110618+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Best Buy Q3: comp sales +2.7%, adj. EPS $1.40; raises FY26 adj. EPS guide to $6.25-$6.35

## Summary
- Revenue $9.672B (+2.4% YoY); Domestic comp +2.4%, International comp +6.3%.
- GAAP diluted EPS $0.66 (includes $192M pre-tax Best Buy Health impairments); adjusted diluted EPS $1.40 vs. $1.26 last year.
- Raises FY26 revenue guidance to $41.65B-$41.95B and adj. diluted EPS to $6.25-$6.35.
- Best Buy Health recorded $171M goodwill/intangible and $21M long-lived asset impairments due to Medicaid/Medicare pressures.
- Board declares $0.95 quarterly dividend, payable Jan 6, 2026 to holders of record Dec 16, 2025.

## SEC filing metadata
- accession: 0000764478-25-000050
- form_type: 8-K
- ticker: BBY
- cik: 0000764478
- company_name: BEST BUY CO INC
- filed_at: 2025-11-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/764478/000076447825000050/0000764478-25-000050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/764478/000076447825000050/bby-20251125.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000764478-25-000050
- JSON: https://secwatch.observer/filing/0000764478-25-000050.json
- Plain text: https://secwatch.observer/filing/0000764478-25-000050.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.